Biogen Inc.: Biogen and Stoke Therapeutics Enter into Collaboration to Develop and Commercialize Zorevunersen for the Treatment of Dravet Syndrome, a Rare Genetic Epilepsy Associated with Refractory Seizures and Neurodevelopmental Impairments
Biogen Inc.: Biogen and Stoke Therapeutics Enter into Collaborat…
Feb 18, 2025
finanznachrichten.de
Biogen Inc.: LEQEMBI IQLIK(lecanemab-irmb) Subcutaneous Autoinjector Named to TIME's Best Inventions of 2025
Biogen Inc.: LEQEMBI IQLIK(lecanemab-irmb) Subcutane…
5 months ago
finanznachrichten.de
Biogen shares soar on landmark Alzheimer's data, lift rivals
1:58
Biogen shares soar on landmark Alzheimer's data, lift rivals
Sep 28, 2022
ReutersNatalie Grover,Manas Mishra
Biogen to Advance Investigational Spinal Muscular Atrophy Asset to Registrational Studies Based on Positive Interim Phase 1 Results
Biogen to Advance Investigational Spinal Muscular Atrophy Asset to …
8 months ago
marketscreener.com
Biogen Inc.: Biogen and Stoke Therapeutics Announce Presentation of Data from Studies of Zorevunersen, an Investigational Medicine for Dravet syndrome, at the 16th European Paediatric Neurology Society (EPNS) Congress
Biogen Inc.: Biogen and Stoke Therapeutics Announce Presentat…
8 months ago
finanznachrichten.de
Biogen shares tank on scrapping Alzheimer trials
1:01
Biogen shares tank on scrapping Alzheimer trials
Mar 22, 2019
ReutersJulie Steenhuysen,Takashi Umekawa
First patient receives controversial Biogen Alzheimer’s drug
1:12
First patient receives controversial Biogen Alzheimer’s drug
Jun 16, 2021
ReutersDeena Beasley
0:47
Biogen Alzheimer's drug closer to approval with U.S. FDA staff backi…
5 months ago
ReutersDeena Beasley,Manojna Maddipatla
Biogen Gets U.S., European Reviews of Higher-Dose Spinraza
Jan 23, 2025
marketscreener.com
1:51
FDA approves first Alzheimer’s drug in nearly 20 years despite controv…
Jun 7, 2021
newsnationnow.com
Biogen Inc.: Biogen and Stoke Therapeutics Announce Presentat…
6 months ago
finanznachrichten.de
Biogen Inc.: LEQEMBI (Lecanemab) Approved for the Treatment of Alz…
5 months ago
finanznachrichten.de
In dramatic turn, Biogen seeks FDA approval for experimental Alzheim…
Oct 22, 2019
goodmorningamerica.com
Biogen CEO Sees New Chapter in Fight Against Alzheimer's
Jun 8, 2021
Bloomberg.comJohn Tozzi
0:25
Biogen seeks FDA approval for experimental Alzheimer's drug
Oct 22, 2019
ABC NewsErin Schumaker
Biogen Inc. : Wedbush est neutre
4 months ago
zonebourse.com
Biogen Inc.: LEQEMBI (lecanemab) IV Maintenance Dosing for the Tre…
5 months ago
finanznachrichten.de
Biogen Inc.: Biogen and Stoke Therapeutics Present Data at the 3…
Feb 9, 2025
finanznachrichten.de
1:32
U.S. approval of Biogen Alzheimer's drug sends shares soaring, haile…
Jun 7, 2021
ReutersJulie Steenhuysen,Deena Beasley
Biogen Inc.: Leqembi? (lecanemab) is the First Medicine that Slows Pr…
11 months ago
finanznachrichten.de
2:06
Biogen to start shipping Alzheimer's drug in about two weeks
Jun 8, 2021
ReutersReuters
US FDA approves Eisai, Biogen Alzheimer's drug
Jan 6, 2023
gmanetwork.com
4:04
Biogen shares surge on upbeat Alzheimer's study results
Sep 28, 2022
CNBC
Biogen Inc.: Biogen Announces Late Breaker and New Data Presentatio…
Oct 22, 2024
finanznachrichten.de
Biogen to invest $2 billion in RTP, open new factory in 2025
7 months ago
wral.com
Biogen Inc.: Biogen to Acquire Alcyone Therapeutics, Expanding …
5 months ago
finanznachrichten.de
Biogen Inc.: Biogen Initiates Phase 3 Study of Felzartamab for the Tre…
8 months ago
finanznachrichten.de
Biogen | LinkedIn
11 months ago
linkedin.com
Biogen, Eisai Say FDA Extends Aducanumab BLA Review Period …
Jan 29, 2021
nasdaq.com
See more videos
Static thumbnail place holder